Viveo

Viveo, founded in 1996 and publicly traded on B3 (VVEO3), stands as a prominent Brazilian healthcare company. It operates as an integrated healthcare ecosystem, positioning itself as the foremost manufacturer and distributor of medical supplies and medications within Brazil. The company's extensive reach serves a diverse clientele, including hospitals, clinics, laboratories, pharmacies, wholesalers, and end consumers, underscoring its critical role in the national healthcare infrastructure. Viveo's strategic approach focuses on providing comprehensive solutions across the healthcare value chain.

The company's operational strength is built upon a robust portfolio of subsidiary companies and brands such as Mafra, Cremer, Tecnocold, Insuma, Prevena, Neve, Mafra Especialidades, Humania, and Healthlog. This diverse group enables Viveo to cover a wide spectrum of product categories, from essential first aid and surgical supplies to advanced wound care, vital vaccines, sterile injectable solutions, and specialized medications. This broad offering ensures Viveo can meet complex medical needs. Meet Viveo's team to understand the expertise driving these operations.

With a significant scale of operations, Viveo generates substantial revenue, reported at $1.8B. The company employs a workforce ranging from 5,000-10,000 employees, reflecting its considerable operational footprint. Its primary market focus is Brazil, with strategic implications for the broader South American region, as indicated by its #southamerica hashtag. Viveo's commitment to manufacturing excellence and distribution efficiency solidifies its leadership position in the Brazilian medical supply and pharmaceutical sector.